Financial attributes – Purple Ribbon Project http://purpleribbonproject.com/ Wed, 21 Sep 2022 02:53:36 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://purpleribbonproject.com/wp-content/uploads/2021/10/icon-12.png Financial attributes – Purple Ribbon Project http://purpleribbonproject.com/ 32 32 NDR Auto Components Limited (NSE:NDRAUTO) stock has seen strong momentum: does that call for further study of its financial outlook? https://purpleribbonproject.com/ndr-auto-components-limited-nsendrauto-stock-has-seen-strong-momentum-does-that-call-for-further-study-of-its-financial-outlook/ Wed, 21 Sep 2022 02:53:36 +0000 https://purpleribbonproject.com/ndr-auto-components-limited-nsendrauto-stock-has-seen-strong-momentum-does-that-call-for-further-study-of-its-financial-outlook/ Most readers will already know that shares of NDR Auto Components (NSE: NDRAUTO) are up a significant 49% over the past three months. As most know, fundamentals are what generally guide market price movements over the long term, so we decided to take a look at key financial indicators in business today to see if […]]]>

Most readers will already know that shares of NDR Auto Components (NSE: NDRAUTO) are up a significant 49% over the past three months. As most know, fundamentals are what generally guide market price movements over the long term, so we decided to take a look at key financial indicators in business today to see if they have a role to play. play in the recent price movement. Specifically, we decided to study the ROE of NDR Auto Components in this article.

Return on equity or ROE is a key metric used to gauge how effectively a company’s management is using the company’s capital. In simpler terms, it measures a company’s profitability relative to equity.

Check out our latest analysis for NDR Auto Components

How is ROE calculated?

The return on equity formula is:

Return on equity = Net income (from continuing operations) ÷ Equity

So, based on the above formula, the ROE for NDR Auto Components is:

8.7% = ₹166 million ÷ ₹1.9 billion (based on the last twelve months to June 2022).

The “yield” is the amount earned after tax over the last twelve months. One way to conceptualize this is that for every ₹1 of share capital it has, the company has made a profit of ₹0.09.

What does ROE have to do with earnings growth?

So far we have learned that ROE is a measure of a company’s profitability. We now need to assess how much profit the company is reinvesting or “retaining” for future growth, which then gives us an idea of ​​the company’s growth potential. Generally speaking, all things being equal, companies with high return on equity and earnings retention have a higher growth rate than companies that do not share these attributes.

A side-by-side comparison of NDR Auto Components’ earnings growth and ROE of 8.7%

As you can see, the ROE of NDR Auto Components seems quite low. Not only that, even compared to the industry average of 11%, the company’s ROE is quite unremarkable. Despite this, NDR Auto Components has been able to significantly increase its net profit, at a rate of 29% over the past five years. Therefore, there could be other reasons behind this growth. Such as – high revenue retention or effective management in place.

We then compared the net income growth of NDR Auto Components with the industry and we are glad to see that the growth figure of the company is higher compared to the industry which has a growth rate of 5, 2% over the same period.

NSEI: NDRAUTO Past Earnings Growth September 21, 2022

The basis for attaching value to a company is, to a large extent, linked to the growth of its profits. It is important for an investor to know whether the market has priced in the expected growth (or decline) in the company’s earnings. This then helps them determine if the stock is positioned for a bright or bleak future. If you’re wondering about the valuation of NDR Auto Components, check out this indicator of its price/earnings ratio, relative to its industry.

Does NDR Auto Components use its profits efficiently?

NDR Auto Components’ three-year median payout ratio to shareholders is 8.5%, which is quite low. This implies that the company retains 92% of its profits. This suggests that management reinvests most of the profits to grow the business, as evidenced by the growth seen by the business.

While NDR Auto Components has seen earnings growth, it only recently started paying a dividend. Chances are the company has decided to impress new and existing shareholders with a dividend.

Conclusion

Overall, we think NDR Auto Components has positive attributes. With a high reinvestment rate, albeit at a low ROE, the company managed to see considerable growth in earnings. While we wouldn’t completely dismiss the business, what we would do is try to figure out how risky the business is to make a more informed decision about the business. To learn about the 3 risks we have identified for NDR Auto Components, visit our risk dashboard for free.

This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.

Valuation is complex, but we help make it simple.

Find out if NDR auto components is potentially overvalued or undervalued by viewing our full analysis, which includes fair value estimates, risks and warnings, dividends, insider trading and financial health.

See the free analysis

]]>
Down 19% since June, what’s next for Rio Tinto’s share price? https://purpleribbonproject.com/down-19-since-june-whats-next-for-rio-tintos-share-price/ Mon, 19 Sep 2022 01:33:14 +0000 https://purpleribbonproject.com/down-19-since-june-whats-next-for-rio-tintos-share-price/ Image source: Getty Images The Rio Tinto Limited (ASX: RIO) The stock price has plunged in recent months, losing nearly 19% since June 1. Shares of Rio started in June at $114.91 each and are currently trading at $93.24 a share. Meanwhile, the S&P/ASX 200 Materials Index (ASX:XMJ) also took a hit over the same […]]]>

Image source: Getty Images

The Rio Tinto Limited (ASX: RIO) The stock price has plunged in recent months, losing nearly 19% since June 1.

Shares of Rio started in June at $114.91 each and are currently trading at $93.24 a share.

Meanwhile, the S&P/ASX 200 Materials Index (ASX:XMJ) also took a hit over the same period, losing around 13%.

But there are a few insights and new developments to consider that could put this performance in a new light. We’ll take a look.

What’s happening in China?

There is a glimmer of optimism that the woes of China’s housing crisis may begin to ease, as my colleague Fool Monica has reported.

China has been reported to be stepping up support for its housing industry and easing some restrictions in its ongoing zero-COVID policies.

In a research note released on Friday, ANZ’s Australian economics chief David Plank said the easing of curfews in the city of Chengdu had improved the outlook for iron ore demand.

On the same day, Morgan Stanley also refined its outlook for aluminum. The broker raised its forecast for the price of aluminum by 17% to US$2,525 per tonne.

This followed speculation of widespread cuts in aluminum production in China due to the country’s soaring energy costs.

The importance of the Chinese market?

However, one analyst says Australia’s – and Rio Tinto’s – reliance on China may be an artefact of our prejudices and memories rather than a fact.

Fisher Investments founder Ken Fisher notes that Australian exports to China were down 11.3% year-on-year, despite net Australian export growth of 30.3%.

He attributes this largely to the growth of Australian exports to developed and emerging economies such as South Korea and India, as reported The Australian.

Fisher also provided a deeper analysis of Australia’s perceived overreliance on China.

What did Fisher say?

Fisher noted that China’s explosive growth over the past few decades may have reached a point of diminishing returns, with towns and cities now more interconnected than at any time before.

He argued that the establishment of the interim infrastructure has enabled the Chinese economy to prosper by unifying the channels of its industry. However, now that this phase of meteoric growth is over, he expects it to decline to the levels seen by more developed economies.

China’s gross domestic product (GDP) is expected to grow 3.9% in 2022, a far cry from its peak of 14.2% in 2007.

Fisher noted fears of an ongoing slowdown in China may be overblown, saying “Australia is not a one-trick export pony dependent on the Chinese commodities frenzy.”

He said part of the reason people assume China is central to the health of Australia’s economy and exporters is that during the global financial crisis China was still growing rapidly and its demand for raw materials is what kept Australia’s head above water while other economies floundered.

But, Fisher said, times have changed and there is a long-term correlation between China’s falling GDP and the S&P/ASX 200 Index (ASX: XJO) up:

History shows that slowing Chinese growth in itself does not doom the ASX. After China’s GDP growth peaked at 14.2% in 2007, it slowed in 10 of the following 12 years before the Covid-19 bias that followed. The ASX 200 has risen in nine of those 12 years, climbing 150.5%, outperforming global stocks by 132.8%.

Driving the point home, Fisher concluded:

Inflated China fears have dogged Australian stocks for years. But remember: false fears are bullish, always and everywhere. Just like feeling depressed. Don’t let today’s gloomy headlines scare you away from the recovery to come.

Rio Tinto share price overview

Rio Tinto’s share price is down 6.9% year-to-date and 5.7% over the past 12 months.

This compares to the ASX 200’s nearly 10% decline in 2022 so far and the 9% loss in the past year.

Rio’s current market capitalization is approximately $34.6 billion.

]]>
Could the market be wrong about OEM International AB (publ) (STO:OEM B) given its attractive financial outlook? https://purpleribbonproject.com/could-the-market-be-wrong-about-oem-international-ab-publ-stooem-b-given-its-attractive-financial-outlook/ Sat, 17 Sep 2022 08:39:43 +0000 https://purpleribbonproject.com/could-the-market-be-wrong-about-oem-international-ab-publ-stooem-b-given-its-attractive-financial-outlook/ OEM International (STO:OEM B) had a difficult month with a 25% decline in its share price. However, a closer look at his healthy finances might make you think again. Since fundamentals generally determine long-term market outcomes, the company is worth looking into. In this article, we have decided to focus on the ROE of OEM […]]]>

OEM International (STO:OEM B) had a difficult month with a 25% decline in its share price. However, a closer look at his healthy finances might make you think again. Since fundamentals generally determine long-term market outcomes, the company is worth looking into. In this article, we have decided to focus on the ROE of OEM International.

Return on Equity or ROE is a test of how effectively a company increases its value and manages investors’ money. In other words, it reveals the company’s success in turning shareholders’ investments into profits.

Check out our latest analysis for OEM International

How to calculate return on equity?

Return on equity can be calculated using the formula:

Return on equity = Net income (from continuing operations) ÷ Equity

So, based on the above formula, the ROE for OEM International is:

41% = 531 million kr ÷ 1.3 billion kr (based on the last twelve months until June 2022).

The “yield” is the profit of the last twelve months. One way to conceptualize this is that for every SEK1 of share capital it has, the company has made a profit of SEK 0.41.

Why is ROE important for earnings growth?

We have already established that ROE serves as an effective profit-generating indicator for a company’s future earnings. Depending on how much of those earnings the company reinvests or “keeps”, and how efficiently it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, all things being equal, companies with high return on equity and earnings retention have a higher growth rate than companies that do not share these attributes.

OEM International earnings growth and ROE of 41%

First, we appreciate that OEM International has an impressive ROE. Second, a comparison with the average industry-reported ROE of 20% also does not go unnoticed for us. Probably because of this, OEM International has been able to see a decent 18% net income growth over the past five years.

As a next step, we compared OEM International’s net income growth with the industry and found that the company had a similar growth figure compared to the industry average growth rate of 17% over the past of the same period.

OM:OEM B Past Earnings Growth September 17, 2022

The basis for attaching value to a company is, to a large extent, linked to the growth of its profits. It is important for an investor to know whether the market has priced in the expected growth (or decline) in the company’s earnings. This then helps them determine if the stock is positioned for a bright or bleak future. A good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings outlook. Thus, you might want to check whether OEM International is trading on a high P/E or a low P/E, relative to its industry.

Does OEM International effectively reinvest its profits?

OEM International has a healthy combination of a moderate three-year median payout ratio of 45% (or a retention rate of 55%) and respectable earnings growth, as we saw above, this which means that the company has made efficient use of its profits.

Additionally, OEM International has paid dividends over a period of at least ten years, which means the company is pretty serious about sharing its profits with its shareholders.

Summary

All in all, we are quite satisfied with OEM International’s performance. In particular, we appreciate the fact that the company is reinvesting heavily in its business, and at a high rate of return. Unsurprisingly, this led to impressive earnings growth. If the company continues to increase earnings as it has, it could have a positive impact on its share price given how earnings per share influence prices over the long term. Not to mention that stock price results also depend on the potential risks that a company may face. It is therefore important for investors to be aware of the risks associated with the business. You can see the 2 risks we have identified for OEM International by visiting our risk dashboard for free on our platform here.

This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.

Valuation is complex, but we help make it simple.

Find out if OEM International is potentially overvalued or undervalued by viewing our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider trading and financial health.

See the free analysis

]]>
Most of Kansas continues to see high rate of new COVID-19 cases https://purpleribbonproject.com/most-of-kansas-continues-to-see-high-rate-of-new-covid-19-cases/ Wed, 14 Sep 2022 19:03:35 +0000 https://purpleribbonproject.com/most-of-kansas-continues-to-see-high-rate-of-new-covid-19-cases/ The Kansas Department of Health and Environment released its latest COVID-19 statistics on Wednesday. As of 9 a.m., there were 4,164 new cases and 45 new deaths reported since Wednesday, September 7, bringing the total statewide death toll to 9,072 since the start of the pandemic. The increase in deaths has been attributed to reconciliation […]]]>

The Kansas Department of Health and Environment released its latest COVID-19 statistics on Wednesday. As of 9 a.m., there were 4,164 new cases and 45 new deaths reported since Wednesday, September 7, bringing the total statewide death toll to 9,072 since the start of the pandemic. The increase in deaths has been attributed to reconciliation of death data from the Bureau of Vital Statistics and does not necessarily reflect an increase in recent deaths.

The weekly cumulative incidence rate, also known as the weekly new case rate, shows that most of Kansas ranks “high,” meaning 100 or more cases per 100,000 population. This was true for all counties in the region except Rice, which showed a “substantial” rate of 50 to 99 cases per 100,000. Statewide, four counties: Cheyenne, Rawlins, Greeley, Edwards and Kiowa, had no new cases for the period beginning September 3 and ending September 9. The most recent five days are not included as the data should be incomplete.

Here are the new case totals for this period from counties in the region:

• Barton 42

• Ellsworth 10

• Pawnee 10

• Rice 5

• Rush 6

• Russell 8

• Stafford 10

Frequently Asked: I have to be quarantined for 14 days and I don’t have enough time off from work to cover it. Will the state pay my salary since I have to be quarantined?

KDHE replies: If you are not working or have reduced hours due to COVID-19, you may be eligible for unemployment insurance benefits. The Unemployment Insurance (UI) program was created to protect those who are unemployed through no fault of their own. It is designed to be a short-term assistance program and may be able to help those whose employment has been affected by COVID-19. Contact the Kansas Department of Labor (KDOL) in your area if you have questions or for more information on the KDOL website (dol.ks.gov/home).

A reader asks: Can I get financial assistance to cover funeral expenses for a loved one who died of COVID-19?

Great Bend Tribune responds: We found this information at https://www.kansastag.gov/press_release_detail.asp?PRid=18680

• 21-021 Financial assistance available through FEMA for funeral expenses related to COVID-19

If your family has incurred funeral expenses due to the COVID-19 pandemic, you may be eligible for financial assistance.

Under the Coronavirus Response and Relief Supplemental Appropriations Act of 2021 and the American Rescue Plan Act of 2021, FEMA provides financial assistance for COVID-19-related funeral expenses incurred after January 20, 2020.

To access information and assistance, call the COVID-19 Funeral Helpline, 844-684-6333 | TTY: 800-462-7585, Monday through Friday, 8 a.m. to 8 p.m. local time. Call this dedicated toll-free number to get a completed COVID-19 Funeral Assistance Application with the assistance of FEMA representatives. Multilingual services will be available.

If you use a relay service, such as your videophone, Innocaption or CapTel, please provide your specific number assigned to this service. It is important that FEMA can contact you, and you should be aware that phone calls from FEMA may come from an unidentified number.

To be eligible for funeral assistance, you must meet these conditions: The death must have occurred in the United States, including US territories, and the District of Columbia.

– The death certificate must indicate that the death was attributed to COVID-19.

– Applicant must be a U.S. citizen, noncitizen, or qualified alien who incurred funeral expenses after January 20, 2020.

– It is not necessary that the deceased person was a US citizen, non-citizen or qualified alien.

We encourage you to retain and collect all funeral-related documents. Types of information should include:

– An official death certificate that attributes the death directly or indirectly to COVID-19 and shows that the death occurred in the United States, including US territories, and the District of Columbia.

– Funeral expense documents (receipts, funeral home contract, etc.) that include the name of the claimant, the name of the deceased, the amount of funeral expenses, and the dates the funeral expenses were incurred.

– Proof of funds received from other sources specifically for funeral expenses. We are unable to duplicate benefits received from funeral or funeral insurance, financial assistance received from voluntary organizations, government agencies or other sources.

– If you are eligible for funeral assistance, you will receive a check by mail or by direct deposit, depending on the option you choose when you request assistance.

Additional resources can be found by going online to https://www.fema.gov/disasters/coronavirus/economic/funeral-assistance

Great Bend Tribune readers can send questions to editor-in-chief Susan Thacker by emailing sthacker@gbtribune.com.

]]>
Matrixport expands Fiat’s loading and unloading ramp capabilities with Cabital https://purpleribbonproject.com/matrixport-expands-fiats-loading-and-unloading-ramp-capabilities-with-cabital/ Tue, 13 Sep 2022 02:00:00 +0000 https://purpleribbonproject.com/matrixport-expands-fiats-loading-and-unloading-ramp-capabilities-with-cabital/ Flagship partnership makes it easy for users to get their crypto at attractive rates via bank transfers SINGAPORE, September 13, 2022 /PRNewswire/ — matrix portone of the largest digital asset financial services ecosystems in the world, today announced a partnership with Cabal, a leading institution in the field of digital assets. As part of the […]]]>

Flagship partnership makes it easy for users to get their crypto at attractive rates via bank transfers

SINGAPORE, September 13, 2022 /PRNewswire/ — matrix portone of the largest digital asset financial services ecosystems in the world, today announced a partnership with Cabal, a leading institution in the field of digital assets. As part of the deal, Matrixport will integrate Cabital Connect’s comprehensive fiat on and off ramp solution into its platform, allowing users to convert a wide range of fiat currencies, including GBP, EUR and CHF. , into cryptocurrencies and vice versa instantly.

Matrixport users are now able to maximize returns from their investment products thanks to Cabital’s competitive exchange rates, low transaction fees and local payment capabilities.

Kavi Saglani, SVP Marketing & Communications of Matrixport said, “Our customers now have more ways to get their crypto. The partnership with Cabital complements and expands our on-ramp offerings with the same high level of convenience and user-friendly experience that our customers have come to expect. These are important attributes that are crucial to embracing the next wave of digital asset adoption.”

“As the crypto and Web3 ecosystem continues to grow, there is increasing demand from partners to build a compliance-centric fiat-to-crypto on-and-off ramp that allows users to securely purchase cryptos through localized payment methods,” said Raymond Hsuco-founder and CEO of Cabital. “This added flexibility is another step in our mission to make crypto accessible to everyone and provide a simple, secure, and sensible user experience.”

Specifically, Matrixport platform customers can buy and sell crypto using local wire transfer methods through Cabital Connect. High net worth individuals will benefit from higher transaction limits, allowing them to adapt quickly and take advantage of market changes.

For more information on how Matrixport users can get their crypto, click here.

About Matrixport:

matrix port is one of the largest and most trusted digital asset financial services ecosystems in the world. With USD4B in actively managed digital assets, it provides one-stop crypto financial services to meet emerging needs for long-term wealth generation in digital assets. The company’s services include Cactus Custody™, spot OTC, fixed income, structured products, lending as well as asset management. For more information, please visit www.matrixport.com

About Cabal:

Cabal is a trusted digital financial institution that enables users to buy and sell cryptocurrency and provides compliant and secure cryptographic payment infrastructure and solutions for businesses. One of the business solutions is Cabal Connection, a secure fiat ingress and egress gateway that allows users to purchase cryptocurrencies at some of the most competitive rates in the industry. For more information, please visit www.cabital.com

Logo- https://mma.prnewswire.com/media/1560145/matrixport_logo_blue_white_Logo.jpg

SOURCE matrix port

]]>
Telephony Application Server Market Report 2021, Trends, Competitive Landscape and Opportunities https://purpleribbonproject.com/telephony-application-server-market-report-2021-trends-competitive-landscape-and-opportunities/ Sun, 11 Sep 2022 06:38:19 +0000 https://purpleribbonproject.com/telephony-application-server-market-report-2021-trends-competitive-landscape-and-opportunities/ The business intelligence report on Telephony Application Server market facilitates businesses and other stakeholders to embark on revenue generation sprees by efficiently tackling the current and upcoming challenges in this vertical. It covers all other significant aspects such as predominant trends, primary growth stimulants, and opportunities that govern the industry behavior. Moreover, […]]]>




The business intelligence report on Telephony Application Server market facilitates businesses and other stakeholders to embark on revenue generation sprees by efficiently tackling the current and upcoming challenges in this vertical. It covers all other significant aspects such as predominant trends, primary growth stimulants, and opportunities that govern the industry behavior.

Moreover, the report illuminates the factors contributing to the progress of each market segment, while simultaneously uncovering the top revenue prospects. Besides, it comprises of a comparative study of the past and present business scenario to provide a better understanding of the performance of the market and sub-markets over the analysis period.

Proceeding further, the document appraises the competitive arena, disclosing the status of the key players, emerging competitors, and new entrants in the marketplace. Further, it inspects the consequences of COVID-19 to precisely forecast the growth trajectory of this domain for the approaching years.

Request Sample Copy of this Report @ https://www.newsorigins.com/request-sample/61480

Key points from the Telephony Application Server market report table of contents:

Product landscape

  • Product line: software and services
  • Combined earnings and industry share of each product type
  • Forecast the growth rate of each product type over the analysis period

Scope

  • Application Spectrum: Education, BFSI, Manufacturing, Healthcare, Defense, Retail & e-Commerce, Media & Entertainment, IT & Telecommunications, Oil & Gas, by Region, North America, USA, Canada, Europe , Germany, France, UK, Italy, Russia, Nordic, Rest of Europe, Asia-Pacific, China, Japan, South Korea, Southeast Asia, India, Australia, Rest of Asia, America Latin America , Mexico , Brazil , Rest of Latin America , Middle East & Africa , Turkey , Saudi Arabia , United Arab Emirates , Rest of MEA , , By Company , IBM , Microsoft , Apache , Cisco , RedHat , SAP , Adobe Systems, Oracle, Attachmate, NEC, Software AG and Fujitsu
  • Market share and product demand of each application segment
  • Growth rate of each application segment over the forecast period

Geographic scope

  • Regional bifurcation: North America, Europe, Asia-Pacific, South America, Middle East and Africa, Southeast Asia
  • Total revenue and sales generated by each regional market
  • Approximations of the growth rate of regional markets over the estimated period

Competitive arena

  • Key Market Players: IBM Microsoft Apache Cisco RedHat SAP Adobe Systems Oracle Attachmate NEC Software AG Fujitsu
  • Assessment of the market concentration ratio
  • Detailed data of major companies including their business profiles, product portfolios and manufacturing units in the areas served
  • Figures regarding the pricing model, market share, sales and other financial attributes of the mentioned organizations
  • Archives of the latest mergers, acquisitions and expansion strategies

In brief, the document includes a granular assessment of the Telephony Application Server market by inspecting the various segments of the industry. It also assesses this vertical by exposing the industry supply chain, recognizing downstream consumers, distribution channel, and upstream suppliers, to direct businesses in proficiently marketing their products and services.

Influence of the Phone Application Server Market Report:

  • Comprehensive assessment of all opportunities and risks in the Telephony Application Server Market.
  • Recent innovations and major events in the telephony application server market.
  • A detailed study of business strategies for growth of the Telephony Application Server Market-leading players.
  • Revealing study on the growth area of ​​Telephony Application Server Market for forthcoming years.
  • In-depth understanding of major and minor Telephony Application Server market drivers, restraints and markets.
  • Favorable impression amid vital technological and market latest trends striking the Telephony Application Server Market.

The vast assortment of charts, graphs, charts, and graphs obtained in this market research report generates a strong niche for in-depth analysis of the ongoing trends in the Telephony Application Server market. The report also examines the latest developments and advancements among key market players such as mergers, partnerships, and achievements.

Phone Application Server Market Research Reports Include PESTLE Analysis:

  • PORTER’s Five Forces Analysis
  • Analysis of the competition scenario in the market
  • Product life cycle analysis
  • Analysis of production by region/company

Telephony Application Server Market Drivers affecting:

In short, the Global Telephony Application Server Market report offers a one-stop solution for all the key players covering various aspects of the industry such as growth statistics, development history, share of industry, telephony application server market presence, potential buyers, consumption forecast, data. sources, and beneficial conclusion.

MAJOR REPORT TOC:

Chapter 1 Industry Overview

Chapter 2 Production Market Analysis

Chapter 3 Sales Market Analysis

Chapter 4 Consumption Market Analysis

Chapter 5 Comparative Analysis of Production, Sales and Consumption Market

Chapter 6 Major Manufacturers Production and Sales Market Comparison Analysis

Chapter 7 Major Product Analysis

Chapter 8 Major Application Analysis

Chapter 9 Industry Chain Analysis

Chapter 10 Global and Regional Market Forecast

Chapter 11 Major Manufacturers Analysis

Chapter 12 New Project Investment Feasibility Analysis

Chapter 13 Conclusions

Chapter 14 Appendix

Customization request for this report @ https://www.newsorigins.com/request-for-customization/61480

]]>
Immunovant announces two new development programs for https://purpleribbonproject.com/immunovant-announces-two-new-development-programs-for/ Wed, 07 Sep 2022 10:30:00 +0000 https://purpleribbonproject.com/immunovant-announces-two-new-development-programs-for/ Plan to initiate a pivotal Phase 2b trial in chronic inflammatory demyelinating polyneuropathy (CIDP) in the second half of 20221 with first open period 1 results expected in the first half of 2024 Plan to initiate a phase 2 trial in Graves’ disease in early 2023 with first results expected in the second half of […]]]>
  • Plan to initiate a pivotal Phase 2b trial in chronic inflammatory demyelinating polyneuropathy (CIDP) in the second half of 20221 with first open period 1 results expected in the first half of 2024
  • Plan to initiate a phase 2 trial in Graves’ disease in early 2023 with first results expected in the second half of 2023
  • Immunovant expects a robust cadence of data each semester from the second half of 2023 through the first half of 2025, including multiple clinical readouts in CIDP, Graves’ disease, myasthenia gravis (MG), and thyroid eye disease (TED)
  • Company management will host a webcast for investors today at 8 a.m. ET, accessible here.

NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal life for people with autoimmune diseases, today announced plans to develop batoclimab in chronic inflammatory demyelinating polyneuropathy and Graves’ disease. .

“We are delighted to announce the addition of two new target indications for batoclimab, one of which will be a pivotal program, confirming our confidence in the broad development opportunity for batoclimab,” said Pete Salzmann, MD, Chief Executive Officer. of Immunovant. “Evidence suggests that CIDP and Graves’ disease are caused by autoantibodies and that targeting FcRn is a compelling therapeutic strategy. We believe that both indications present promising opportunities ripe for innovation.

“CIDP represents a multi-billion dollar market for IVIG and a compelling opportunity for the anti-FcRn class, as current therapies for this complex disease have significant safety, tolerability and logistical limitations. We designed our pivotal Phase 2b study by leveraging insights from historic and ongoing clinical trials in this disease, with the goal of improving the likelihood of success and size of effect, while investigating multiple doses for optimal differentiation,” added Bill Macias, MD, Chief Medical Officer. at Immunovant.

“With respect to Graves’ disease, current treatments leave a significant proportion of patients unable to achieve normal thyroid hormone function and many remain symptomatic even under current treatments,” Dr. Salzmann said. “As a classic autoantibody condition, the simple biology of Graves’ disease, from pathogenic autoantibodies to altered hormones, provides strong scientific rationale for the indication, supported by anecdotal data from our trial of phase 2b on thyroid eye disease. By more precisely defining the dose-response of batoclimab in Graves’ disease, we believe that our Graves Phase 2 trial, if successful, can inform and significantly reduce the risks of a future Phase 3 trial and help bring new therapy to a large patient population that requires additional treatment.

With the addition of these development programs, Immunovant is now pursuing the clinical development of batoclimab in five indications, including MG and TED which have already disclosed data readouts. Immunovant expects to finalize its trial design in warm autoimmune hemolytic anemia following interactions with regulators later in 2022.

Webcast for investors

Immunovant will host a webcast for investors today at 8 a.m. ET. The webcast will feature prepared remarks from company management and key external opinion leaders and highlight the current treatment landscape for CIDP and Graves’ disease, as well as plans to study the potential of batoclimab. to meet the unmet needs of its target patient populations. A live Q&A with company management will follow the official presentations.

Guest speakers will include:

  • George Kahaly, MD, PhD, Professor of Medicine and Endocrinology/Metabolism at Johannes Gutenberg University Medical Center (JGU)
  • Jonathan Katz, MD, Director, Neuromuscular Clinic, California Pacific Medical Center
  • Todd Levine, MD, Medical Director, Department of Neurology, Honor Health Scottsdale, Arizona

To access the webcast, please register here. An archived recording of the webcast will be available on Immunovant’s website for a limited time after its conclusion.

About Immunovant, Inc.
Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal life for people with autoimmune diseases. As a leader in FcRn inhibitor technology, the company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs. The Company’s investigational compound, batoclimab, is a novel fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn). For more information about the company, please visit www.immunovant.com.

Forward-looking statement
This press release contains forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as “may”, “could”, “could”, “will”, “would”, “should”, “expect”, “believe”, “estimate”, “conceive”, “plans”, “intends” and other similar expressions are intended to identify forward-looking statements. These forward-looking statements include Immunovant’s plan to initiate a Phase 2b clinical trial for batoclimab in CIDP in the second half of calendar year 2022, with early open-label Period 1 results expected in the first semester of calendar year 2024; Immunovant’s plan to initiate a Phase 2 clinical trial for batoclimab in Graves’ disease in early calendar year 2023 with initial results expected in the second half of calendar year 2023; Immunovant’s plan to finalize its trial design in warm autoimmune hemolytic anemia following expected interactions with regulators later in calendar year 2022; Immunovant’s plan to develop batoclimab in a wide range of other autoimmune indications; timing of discussions with regulators; the size and growth of potential markets for Immunovant’s product candidate and indication selections; Immunovant’s expectations regarding the timing, design and results of clinical trials of its product candidates and indication selections; and the potential benefits of the unique features of the batoclimab product. All forward-looking statements are based on estimates and assumptions of Immunovant’s management which, although Immunovant believes to be reasonable, are inherently uncertain. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those Immunovant expected. These risks and uncertainties include, among others: initial results or other preliminary analyzes or early clinical trial results may not be predictive of final trial results or subsequent clinical trial results; the timing and availability of clinical trial data; timing of discussions with regulators, as well as potential regulatory submissions and approvals; the further development of Immunovant’s product candidate, including the timing of commencement of additional clinical trials; Immunovant’s scientific approach, clinical trial design, selection of indications and general development progress; future clinical trials may not confirm the safety, potency or other product characteristics described or implied in this press release; any product candidates developed by Immunovant may not progress through clinical development or receive required regulatory approvals on time or at all; Immunovant’s product candidate may not benefit patients, or even if approved by regulatory authorities, be successfully marketed; the potential impact of the ongoing COVID-19 pandemic, geopolitical tensions and adverse macroeconomic conditions on Immunovant’s clinical development plans and schedules; Immunovant’s business is highly dependent on the successful development, regulatory approval and commercialization of its sole product candidate, batoclimab; Immunovant is in an early stage of batoclimab development; and Immunovant will need additional capital to fund its operations and advance batoclimab through clinical development. These and other risks and uncertainties are more fully described in Immunovant’s periodic and other reports filed with the Securities and Exchange Commission (SEC), including in the section entitled “Risk Factors” of the latest Immunovant’s annual report on Form 10-K, its Form 10-Q filed with the SEC on August 5, 2022, and Immunovant’s subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Immunovant undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact:
Tom Dorney, MS, MBA
Director, Investor Relations and Strategy
Immunovant, Inc.
info@immunovant.com

]]>
Down 78% in one year, could Aston Martin’s share price still be a value trap? https://purpleribbonproject.com/down-78-in-one-year-could-aston-martins-share-price-still-be-a-value-trap/ Mon, 05 Sep 2022 16:35:54 +0000 https://purpleribbonproject.com/down-78-in-one-year-could-aston-martins-share-price-still-be-a-value-trap/ Image source: Getty Images luxury car manufacturer Aston Martin (LSE: AML) is good for making cars that move at high speed. Aston Martin’s share price has also been moving at high speed lately, but in reverse. Over the past year, it has collapsed by 78%. Despite this, I still fear that stocks are a value […]]]>

Image source: Getty Images

luxury car manufacturer Aston Martin (LSE: AML) is good for making cars that move at high speed. Aston Martin’s share price has also been moving at high speed lately, but in reverse. Over the past year, it has collapsed by 78%.

Despite this, I still fear that stocks are a value trap and I will not buy them for my portfolio.

A good deal but a bad investment

A costly mistake that many new investors make is to confuse a company’s potential with its attractiveness as an investment. I think Aston Martin is a good example of that.

The company itself has a lot to love. Its iconic brand is loved by car enthusiasts around the world, allowing the company to charge high prices. Volumes are quite low, which means there is room to grow in the future. In recent years, the company has diversified into sport utility vehicles, expanding its potential customer base.

But if the company has these attractive attributes, why do I think it might be a value trap if I invest in it? It’s because of the way it’s financially structured. The company’s balance sheet is bloated with debt. At the half-year stage, net debt had risen to £1.3 billion. Even if the company does well, the need to repay that debt could keep Aston Martin’s share price depressed.

The woes of the balance sheet

The automaker has a plan to deal with its problematic balance sheet, however.

Aston Martin today announced that it has raised approximately £576million in a rights issue. This could help reduce debt and improve the company’s liquidity cushion. I have my doubts, however, about how transformative it can be. The company plans to use no more than half of the new funds to reduce debt. So I expect net debt to remain high for the foreseeable future.

But the downside is that the rights issue will heavily dilute existing shareholders, not for the first time in several years. I have long viewed additional dilution as a risk of owning Aston Martin shares and it has happened.

Stock price crash

After falling 9% on today’s news at the time of writing, Aston Martin’s share price is now 96% below where it was listed on the stock market just four years ago . Part of this drop reflects the huge dilution in equities seen during this period.

Despite this drop, I continue to avoid adding stocks to my portfolio. The rights issue will help strengthen Aston Martin’s finances and investors alike Mercedes-Benz buy. But they can have strategic goals, not purely financial goals like me.

What I see is a company with a lot of debt, a history of massive shareholder dilution, and risks like a recession hurting sales. Management has been cut and changed several times in recent years and I lack confidence in the investment case from a small private investor’s perspective. Even at this point, I see it as a potential value trap. The collapse in Aston Martin’s share price does not tempt me to buy for my portfolio.

]]>
Decision of a lifetime – Central Queensland Today https://purpleribbonproject.com/decision-of-a-lifetime-central-queensland-today/ Sun, 04 Sep 2022 00:00:24 +0000 https://purpleribbonproject.com/decision-of-a-lifetime-central-queensland-today/ STEPS graduate and psychologist Doreen Canoy (right) talks to psychology graduate Claire Dowling about future career prospects. Picture provided. Twenty-two years after graduating from high school and fulfilling her role as a mother, Doreen Canoy made the momentous decision to enroll in CQUniversity’s Skills for College Preparatory Studies (STEPS) course. What started as the first […]]]>

STEPS graduate and psychologist Doreen Canoy (right) talks to psychology graduate Claire Dowling about future career prospects. Picture provided.

Twenty-two years after graduating from high school and fulfilling her role as a mother, Doreen Canoy made the momentous decision to enroll in CQUniversity’s Skills for College Preparatory Studies (STEPS) course.

What started as the first rung on the ladder to developing a career and establishing financial and emotional independence has become so much more for Doreen, who has since pursued a career as a clinical psychologist and academic. .

In 2004, when considering returning to full-time employment after having her children, Doreen wasn’t quite sure what she wanted to do, but she knew she wanted a career and freedom. financial.

She had already completed some online studies but, due to feelings of anxiety, did not complete the final assessment.

It was then that she saw an advertisement for STEPS in the local newspaper, which would change the direction of her life for the better.

Doreen finds STEPS unlike any other type of college education because students learn as much about themselves as they do about their college readiness.

“The skills and knowledge gained in STEPS are beneficial not only for students pursuing a college degree, but also for those obtaining employment after being unemployed for a considerable period,” Doreen said.

“University education is not for everyone; however, everyone deserves to have a purpose and to feel valued.

“These are extremely important goals of STEPS and a strong focus of CQUniversity’s drive to engage the community.”

Reflecting on her professional accomplishments over the past 15 years, Doreen is very proud.

She credits the teaching and wonderful mentorship of the staff at STEPS as the impetus for her decision to apply for a Bachelor of Psychology (Honours) degree.

“STEPS gave me the confidence to know my way around campus, to be comfortable approaching staff, and to feel at home in the library.”

At first, she believed she was ahead of incoming undergraduates who had not completed STEPS.

“I’m pretty sure that without this wonderful introduction to college, I would have felt overwhelmed and certainly out of reach.”

Keen to pass on her direct experience of STEPS and how instrumental this course has been in her individual, professional and personal growth, Doreen said seeing so many others embark on and experience the STEPS journey is what under – tendered his honors thesis.

Doreen successfully completed her undergraduate studies over six years while working part-time, and upon completion she worked for two years before returning to CQUniversity to undertake a Masters in Clinical Psychology.

His work spanned research, the criminal justice system, academia, and community mental health, with each experience building on the next.

She received the Australian Psychological Society Student Award from the APS Clinical College (CCLP) for her clinical thesis.

After completing the Clinical Psychology Registrar course, Doreen is now a Registered Clinical Psychologist.

She returned to CQUniversity several years ago as an academic and became a course leader for the Masters in Professional Psychology – a course she wrote.

Doreen has since returned to full-time clinical practice, and although she misses the interaction with her students, she is extremely happy to engage with clients on a daily basis.

“As scary as it sounds, STEPS has truly changed my life,” she said.

“Without this path, I would never have been confident enough to start the journey.

“And what a journey it has been.”

]]>
AIA’s program in Hong Kong and Macao is underway to attract talent to join the insurance industry https://purpleribbonproject.com/aias-program-in-hong-kong-and-macao-is-underway-to-attract-talent-to-join-the-insurance-industry/ Fri, 02 Sep 2022 01:37:34 +0000 https://purpleribbonproject.com/aias-program-in-hong-kong-and-macao-is-underway-to-attract-talent-to-join-the-insurance-industry/ 閱讀中文版本 HR goes behind the scenes to find out how the program is progressing, as it offers talent e-learning opportunities, as well as a potential cash bonus of HK$20,000 for top performers. In July 2022, AIA Hong Kong announced the launch of its “Start-Up Elite Program” aimed at attracting young talents and professionals to Hong […]]]>

閱讀中文版本

HR goes behind the scenes to find out how the program is progressing, as it offers talent e-learning opportunities, as well as a potential cash bonus of HK$20,000 for top performers.

In July 2022, AIA Hong Kong announced the launch of its “Start-Up Elite Program” aimed at attracting young talents and professionals to Hong Kong and Macao to join the insurance industry. Participants will benefit from access to an array of online learning resources anytime, anywhere, and those who achieve specified goals will become members of the AIA Premier Academy or Financial Planners and receive up to HK$20,000 in cash as a start-up bonus. .

This initiative is part of the insurer’s ongoing efforts for digital transformation, as part of which its AIA Premier Academy is preparing its technology, digital and analytics (TDA) process to support the recruitment and development of talent.

At launch in July, Jim Jan Zen, Branch Manager, AIA Hong Kong and Macaotold the program, “It gives them a fast track to gaining experience to become a financial planner and give them a head start on their career as an entrepreneur.”

The semester program is currently open for applications.

With the program now running for over a month, HR contacted AIA to understand the progress. Zen shared, “Since we launched the Start-Up Elite program in July, the response has been overwhelmingly positive. All applicants are young, high caliber and most of them have university degrees. ‘a very flexible work style, they are looking to start a new page in their careers.’

Alongside this initiative, the AIA Premier Academy, established in 2011, has trained approximately 8,000 Million Dollar Round Table (MDRT) members since 2011.

As the organization continues to welcome young talent with different skills and backgrounds, the following qualities are highly sought after, such as sharing Zen, “entrepreneurial, digitally savvy, passionate about building a better future and yearning to learn and grow”.

In a market where emigration is high and talent is scarce, Zen’s advice for scouting for top talent is to understand what talent is actually looking for: “Young people now seek work-life balance and value a diverse, inclusive and supportive culture.”

Zen adds, “We welcome new ideas and different points of view. Our technological competitiveness also gives us an advantage in attracting candidates. Open-minded, energetic and quick-witted people will find AIA a great place to build. their career.”


Main Image / Shutterstock

Follow us on Telegram and on Instagram @humanresourcesonline for all the latest HR and workforce news from across the region!

]]>